Modeling HIV vaccines in Brazil: Assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Fonseca, Maria Goretti P ^a   Forsythe, Steven ^b   Menezes, Alexandre ^c   Vuthoori, Shilpa ^d   Possas, Cristina ^e   Veloso, Valdiléa ^a   Lucena, Francisca de Fátima ^f   Stover, John ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b AVENIR HEALTH   (United States)

^c INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^d Rabin Strategic Partners   (United States)

^e AIDS e Hepatites Virais   (Brazil)

^f Ministério do Desenvolvimento Social e Combate à Fome   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PROSTITUTION; VACCINATION; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AIDS VACCINES; BRAZIL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77955410119     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011736     Document Type: Article

References (44)

1. Fonseca MGP, Bastos FI (2007) Twenty-five years of the AIDS epidemic in Brazil: principal epidemiological findings, 1980-2005. Cad Saude Publica 23(Sup 3): S333-S344.
2. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de DST, Aids e Hepatites Virais (2008) Boletim Epidemiológico AIDS DST V(01). Available: http://www.aids.gov.br/data/Pages/LUMIS9A49113DPTBRIE.htm. Accessed 2010 Jun 23.
3. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids (2007) Recomendaçôes para Profilaxia da Transmissão Vertical do HIV e Terapia Antirretroviral em Gestantes - 2006. Série Manuais no 46.
4. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids (2008) Plano Nacional de Enfrentamento da Epidemia de Aids e das DST entre gays, HSH e travestis. 2007. Available: http://www.aids.gov.br/main.asp?View=%7BE62A8511%2D7150%2D4615%2D9BFA%2D10FDC4F4E642%7D&Team=¶ms=sLetraFim=Q%3BsLetraIni=P%3B&UIPartUID=%7BC002F320%2D7F48%2D4FD5%2D9036%2D124927BAF21E%7D. Accessed 2010 Jun 22.
5. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de DST, Aids e Hepatites Virais (2010) Recomendaçôes para Terapia Antirretroviral em Adultos Infectados pelo HIV - 2008 - Suplemento II. Available: http://www.aids.gov.br/main.asp?View=%7BE62A8511%2D7150%2D4615%2D9BFA%2D10FDC4 F4E642%7D&Team=¶ms=sLetraFim=S%3BsLetraIni=R%3B&UIPartUID=%7BC002F320%2D7F48%2D4FD5%2D9036%2D124927BAF21E%7D. Accessed 2010 Jun 22.
6. International AIDS Vaccine Initiative (2005) Modeling the Impact of AIDS Vaccines: A Review of the Literature. Policy Research Working Paper #5.
7. Stover J, Garnett GP, Seitz S, Forsythe S (2002) The epidemiological impact of an HIV/AIDS vaccine in developing countries. Policy Research Working Paper 2811. The World Bank. March.
8. Anderson KM, Owens DK, Vardas E, Gray GE, McIntyre JA, et al. (2007) Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries. J Acquir Defic Syndr 46: 78-90.
9. Stover J, Johnson P, Zaba B, Zwahlen M, Dabis F, et al. (2008) The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect 84(Suppl 1): i24-i30. The Spectrum model can be downloaded from www.FuturesInstitute.org. The projection files can be provided by the author upon request.
10. Stover J, Bollinger L, Hecht R, Williams C, Roca E (2007) The Impact of an AIDS Vaccine in Developing Countries: A New Model and Initial Results. Health Affairs 26: 1147-1158.
11. Bollinger LA (2008) How can we calculate the ''E'' in ''CEA''? AIDS 22 (suppl 1): S51-S57.
12. Hacker MA, Leite IC, Renton A, Torres TG, Gracie R, et al. (2006) Reconstructing the AIDS epidemic among injection drug users in Brazil. Cad Saude Publica 22: 751-60.
13. Szwarcwald CL, Carvalho MF, Barbosa jr A, Barreira D, Speranza FA, et al. (2005) Temporal trends of HIV-related risk behavior among Brazilian military conscripts, 1997-2002. Clinics 60: 367-74.
14. Ministerio da Saude. Secretaria de Políticas de Saude. Coorcão Nacional de DST e AIDS (2000) Comportamento Sexual da Populacão Brasileira e Percepcôes do HIV/Aids. Serie Avaliacão No. 4, PN DST e Aids, Brasília, 2000.
15. Ministerio da Saude. Secretaria de Políticas de Saude. Coorcão Nacional de DST e AIDS (2002) Pesquisa entre os Conscritos do Exercito Brasileiro, 1996-2000: Retratos do comportamento de risco do jovem brasileiro a infeccão pelo HIV. Serie Estudos Pesquisas e Avaliacão no 2. Brasília, Ministerio da Saude, CN DST/Aids, 2002.
16. Sociedade Civil Bem-Estar Familiar no Brasil BEMFAM (1996) Programa de Pesquisas de Demografia e Saude (DHS) Macro International Inc, 1997. Brasil Pesquisa Nacional Sobre Demografia e Saude 1996.
17. Pires ICP, Miranda AEB (1998) Prevalencia e Fatores Correlatos de Infeccão pelo HIV e Sífilis em Prostitutas Atendidas em Centro de Referencia DST/ AIDS RBGO, 20(3): 151-154.
18. Ministerio da Saude. Secretaria de Políticas de Saude. Programa Nacional de DST e AIDS (2004) Avaliacão da Efetividade das acôes de Prevencão dirigidas às Profissionais do Sexo, em Tres Regioes Brasileiras. Serie Estudos, Pesquisas e Avaliacão, n°7, Ministerio da Saude, 2004.
19. Ministerio da Saude. Secretaria de Políticas de Saude. Coordcão Nacional de DST e Aids (2001) Projeto Ajude-Brasil: Avaliacão Epidemiológica dos Usuarios de Drogas Injetaveis dos projetos de reducão de danos apoiados pela CN-DST/ AIDS. Serie Avaliacão no 6, Brasília, Ministerio da Saude, 2001.
20. Ministerio da Saude. Secretaria de Políticas de Saude. Coordcão Nacional de DST e Aids (2001) A Contribuicão dos Estudos Multicentricos frente a epidemia de HIV/Aids entre UDI no Brasil: 10 Anos de Pesquisa e Reducão de Danos. Serie Avaliacão no 8, Brasília, Ministerio da Saude, 2001.
21. Mello MB, Pinho A, Chinaglia MLM, Tun W, Barbosa Junior A, et al. (2008) Assessment of risk factors for HIV infection among men who have sex with men in the metropolitan area of Campinas city, Brazil, using respondent-driven sampling. 2008. (Relatorio de pesquisa). Available http://www.popcouncil.org/pdfs/horizons/Brazil_MSMRiskFactors.pdf Accessed 2010Jun 22.
22. Ministerio da Saude. Secretaria de Vigilancia em Saude. Programa Nacional de DST e Aids (2005) PCAP - Pesquisa de Conhecimento, Atitudes e Praticas na Populacao Brasileira de 15 a 54 anos, 2004. Available http://www.aids.gov.br/main.asp? View=%7BE62A8511%2D7150%D4615%2D9BFA%2D10FDC4F4E642%7D&Team=¶ms=sLetraFim=Q%3BsLetraIni=P%3B&UIPartUID=%7BC002F320%2D7F48%2D4FD5%2D9036%2D124927BAF21E%7D. Accessed 2010 Jun 22.
23. Szwarcwald CL, Souza Junior PRB (2006) Estimativa da prevalencia de HIV na populacão brasileira de 15 a 49 anos, 2004. In: Boletim Epidemiologic AIDS DST ano 3 (01):11-15. Available: http://www.aids.gov.br/data/Pages/LUMIS624DE984PTBRIE.htm. Accessed 2010 Jun 22.
24. Brasil Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de DST, Aids e Hepatites Virais (2010) Numero de pacientes em terapia anti-retroviral por regiã o e unidade da federação. Brasil, 1999-2008. Available: http://sistemas.aids.gov.br/monitoraids/?lang=pt-BR&pagina=+&st_lPanel=&indexMenu=0#. Accessed 2010 Jun 22.
25. Pilcher CD, Tien HC, Eron JJ, Vernazza PL, Leu SY, et al. (2004) Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV. J of Infectious Dis 189: 1785-1792.
26. Powers KA, Poole C, Pettifor AE, Cohen MS (2008) Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis The Lancet 8(9): 553-563 Epub 2008 Aug4.
27. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, et al. (1999) Per-Contact Risk of Human Immunodeficiency Virus Transmission between Male Sexual Partners. Am J Epidemiol 150: 3;306-31.
28. Weller S, Davis K (2004) Condom Effectiveness in Reducing Hetersexual HIV Transmission (Cochrane Review). In Cochrane Library, Issue 1, 2004. Chichester, UK. John Wiley & Sons, Ltd.
29. International AIDS Vaccine Initiative (2006) The Impact of an AIDS Vaccine in Developing Countries: A New Model and Preliminary Results. Policy Research Working Paper #8.
30. Barth-Jones DC, Cheng H, Kang LY, Kenya PR, Odera D, et al. (2005) Cost effectiveness and delivery study for future HIV vaccines. AIDS 19 13: w1-6.
31. Barth-Jones DC, Longini Jr. IM (2002) Determining Optimal Vaccination Policy for HIV Vaccines: A Dynamic Simulation Model for the Evaluation of Vaccination Policy. Proceedings of the International Conference on Health Sciences Simulation 2002. Eds. Anderson JG, Katzper, 2002 Western Multi-conference, January 27-31, 2002. San Antonio, Texas.
32. Chor D, Lima CRA (2005) Aspectos Epidemiológicos das Desigualdades Raciaisem Saúde no Brasil. Cad Saude Publica 21: 1586-1594.
33. Jorge MHPM, Gotlieb SLD, Laurenti R (2002) Sistema de Informaçôes sobre Mortalidade: Problemas e Propostas para o seu Enfrentamento I - Mortes por Causas Naturais. Rev Bras Epidemiol 5: 197-211.
34. Blower SM, Dowlatabadi H (1994) Sensitivity and uncertainty and analysis of complex models of disease transmission: an HIV model as an example. Int Statist Rev 2: 229-243.
35. Blower SM, Hartel D, Dowlatabadi H, Anderson RM, May RM (1991) Drugs, sex and HIV: a mathematical model for New York City Philos Trans R Soc Lond B Biol Sci 331(1260): 171-87.
36. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N Engl J Med 361: 1-12.
37. Blower SM, McLean AR (1994) Prophylactic vaccines, risk behavior change and the probability of eradicating HIV in San Francisco. Science 265: 1451-1454.
38. Gray RH, Xianbin L, Wawer MJ, Gange SJ, Serwadda D, et al. (2003) Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17: 1941-1951.
39. Nagelkerke NJD, De Vlas SJ (2003) The Epidemiological Impact of an HIV Vaccine on the HIV/AIDS Epidemic in Southern India. Policy Research Working Paper 2978. Washington, DC: World Bank, February.
40. Owens DK, Edwards DM, Shachter RD (1998) Population effects of preventive and therapeutic HIV vaccines in early- and late-state epidemics. AIDS 18: 1057-1066.
41. Smith RJ, Blower SM (2004) Could disease-modifying HIV vaccines cause population-level perversity? Lancet Infect Dis 4: 636-639.
42. Anderson R, Hanson M (2005) Potential public health impact of imperfect HIV type 1 vaccines. J of Infectious Dis 191(Suppl 1): S85-S96.
43. Edwards DM, Shachter RD, Owens DK (1998) A dynamic HIV-transmission model for evaluating the costs and benefits of vaccine programs. Interfaces 28: 144-166.
44. Blower S, Moss RB, Fernandez-Cruz E (2003) Calculating the potential epidemic-level impact of therapeutic vaccination on the San Francisco HIV epidemic. AIDScience 3: 21.